5-Chloro-1-phenylindole-2-carboxylic acid | 261617-31-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 5-Chloro-1-phenylindole-2-carboxylic acid
• CAS: 261617-31-6
• 化学式: C₁₅H₁₀ClNO₂
• 分子量: 271.703
• InChiKey: XIFLKSQJZKQOAX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  42.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-Chloro-1-phenylindole-2-carboxylic acid 在 氯化亚砜 作用下， 以 二氯甲烷 为溶剂， 生成
  参考文献：
  名称：

  The discovery of novel indole-2-carboxamides as cannabinoid CB1 receptor antagonists

  摘要：

  The discovery and structure-activity relationship of a novel series of indole-2-carboxamide antagonists of the cannabinoid CB1 receptor is disclosed. Compound 26i was found to be a high potency, selective cannabinoid CB1 antagonist. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.10.104
• 作为产物：
  描述：

  在 水 、 potassium hydroxide 作用下， 以 乙醇 为溶剂， 生成 5-Chloro-1-phenylindole-2-carboxylic acid
  参考文献：
  名称：

  The discovery of novel indole-2-carboxamides as cannabinoid CB1 receptor antagonists

  摘要：

  The discovery and structure-activity relationship of a novel series of indole-2-carboxamide antagonists of the cannabinoid CB1 receptor is disclosed. Compound 26i was found to be a high potency, selective cannabinoid CB1 antagonist. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.10.104

文献信息

• The discovery of novel indole-2-carboxamides as cannabinoid CB1 receptor antagonists
  作者：Phillip M. Cowley、James Baker、David R. Barn、Kirsteen I. Buchanan、Ian Carlyle、John K. Clark、Thomas R. Clarkson、Maureen Deehan、Darren Edwards、Richard R. Goodwin、David Jaap、Yasuko Kiyoi、Chris Mort、Ronald Palin、Alan Prosser、Glenn Walker、Nick Ward、Grant Wishart、Trevor Young

  DOI：10.1016/j.bmcl.2010.10.104

  日期：2011.1

  The discovery and structure-activity relationship of a novel series of indole-2-carboxamide antagonists of the cannabinoid CB1 receptor is disclosed. Compound 26i was found to be a high potency, selective cannabinoid CB1 antagonist. (C) 2010 Elsevier Ltd. All rights reserved.